Master Alliance Provisions Guide (MAPGuide)

UK Secretary of State – AstraZeneca, COVID-19 Vaccine Supply Agreement

  • Term & termination | Effects of termination

9. Remedies & Mitigation of Losses


9.5 If the Purchaser rejects any Rejected Product (and does not elect to receive replacement Product), or this Supply Agreement is terminated in the circumstances identified in clause 23.2.2 [note: this clause has been redacted] prior to Delivery of the entire Order, then without prejudice to the Purchaser’s other remedies set out herein:

9.5.1 in so far as AstraZeneca (or its Affiliates or Subcontractors) has purchased, committed to purchase, or reserved any raw materials, equipment and services for the Manufacture of the Product, and AstraZeneca has been paid the portion of the Price allocable to such raw materials, equipment and services, to the extent permitted by the terms of the applicable contract, the Purchaser can elect to acquire and take delivery of (or have its designee or Authorised Agent to acquire and/or take delivery of) any or all of the raw materials, equipment and/or services purchased, to be purchased or reserved by AstraZeneca (or its Affiliates or Subcontractors);

9.5.2 AstraZeneca shall cooperate and act reasonably with the Purchaser to promptly facilitate the transfer or novation to the Purchaser, its designee or Authorised Agent of any such raw materials, equipment or services so elected by the Purchaser.